Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹29.3 LQualified Item Categories: Line Probe Assay for First Line Drugs (Drug resistance testing under NTEP) 43 A OKHLA INDUSTRIAL ESTATE PHASE III NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | Item Categories: Line Probe Assay for First Line Drugs (Drug resistance testing under NTEP) | L1 | Qualified |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
16 Feb 2023, 7:00 pmClosed
Line Probe Assay for First Line Drugs (Drug resistance testing under NTEP) (Q1) ( PAC Only )
4354727
GEM/2023/B/3065477
Single Packet Bid
Line Probe Assay for First Line Drugs (Drug resistance testing under NTEP)
GeM Contract
15 days
Uttar Pradesh; Agra
Total value wise evaluation
PRODUCT
Awarded to BIOMERIEUX INDIA PRIVATE LIMITED
₹29.3 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| HAIN LIFESCIENCE Line Probe Assay for First Line Drugs | HAIN LIFESCIENCE / Genotype MTBDR plus V2 | HSN not specified by seller | 40 pieces | 73,304 | 2,932,160 |
4 documents required · 4 mandatory
1 yrs
₹3
10%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Line Probe Assay for First Line Drugs (Drug resistance testing under NTEP) (Q1) ( PAC Only ) | Brijesh Kumar 282002,State TB Training Demonstration Centre UP, Moti Katra Road, Adjacent S N Medical College, AGRA UP | 40 | 15 days |
Exempted
17 Feb 2023
1 Feb 2023
16 Feb 2023
contract_GEMC-511687785052359.pdf
GEM_CONTRACT • 0.06 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_4354727.pdf
GEM_BID
1675253703.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .